Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast agent presented as a sterile solution for injection for intra‑arterial, intra‑articular and intrathecal use. It provides high‑density iodine atoms that attenuate X‑rays, thereby improving radiographic contrast during diagnostic imaging procedures such as angiography, arthrography and myelography in adult patients. The agent is administered under physician supervision and is intended for use in imaging studies that require clear delineation of vascular structures, joint spaces, or the spinal canal.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron (iomeprol) is an iodinated contrast agent used to enhance radiographic visualization in vascular, joint and spinal imaging.

Angiography: Improves visualization of blood vessels during X‑ray guided procedures. Arthrography: Enhances contrast of joint spaces to delineate cartilage and soft tissue. Myelography: Provides clear imaging of the spinal canal and nerve roots.

Iomeron may be associated with a range of adverse reactions, most of which are mild and transient, while rare events can be severe.

Common Side Effects: - Nausea: transient feeling of sickness after injection. - Warm sensation: brief feeling of heat or flushing. - Metallic taste: temporary metallic sensation in the mouth. - Headache: mild headache occurring shortly after administration. - Injection site pain: soreness at the site of injection. - Vomiting: occasional emesis following the procedure.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction that can be life‑threatening. - Renal impairment: acute kidney injury, especially in patients with pre‑existing renal dysfunction. - Thyroid dysfunction: iodine load may precipitate hyper‑ or hypothyroidism. - Seizures: rare neurologic events, particularly after intrathecal administration. - Cardiac arrhythmia: irregular heart rhythms in susceptible individuals.

Before using Iomeron, clinicians should consider several safety measures. - Assess renal function: evaluate creatinine clearance prior to administration. - Screen for iodine allergy: obtain a detailed history of hypersensitivity to contrast media. - Hydration: ensure adequate fluid intake before and after the procedure. - Monitor thyroid: exercise caution in patients with known thyroid disorders. - Avoid in neonates: not recommended for pediatric use unless essential. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with other medicines; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Iodine‑containing medications: concurrent use may increase total iodine load and risk of toxicity. - Nephrotoxic drugs: co‑administration with aminoglycosides or NSAIDs can exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask contrast‑induced hypertension. - Diuretics: may affect fluid balance and renal clearance. - Metformin: consider temporary discontinuation in patients with reduced renal function.